Clinical trials
Lipid Metabolism Disorders trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 2 |
| Kastle Therapeutics, LLC | 2 |
| Maastricht University Medical Center | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| E.S.stroes | 1 |
| Eli Lilly and Company | 1 |
| German Diabetes Center | 1 |
| NewAmsterdam Pharma | 1 |
| Wageningen University and Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lipid Metabolism Disorders | 12 |
| Dyslipidemias | 5 |
| Hypercholesterolemia | 5 |
| Metabolic Diseases | 5 |
| Atherosclerosis | 4 |
| Genetic Diseases, Inborn | 3 |
| Lipid Metabolism, Inborn Errors | 3 |
| Cardiovascular Diseases | 2 |
| Homozygous Familial Hypercholesterolemia | 2 |
| Hyperlipidemias | 2 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.